by The GMP cell therapy consumables market plays a crucial role in the effective manufacturing of cell-based therapies. GMP cell therapy consumables such as media, reagents, and serums are widely used in the manufacturing process of cell therapies to maintain the quality and purity of cells. These consumables help support cell growth, cell processing, and storage processes in cell therapy manufacturing. Factors such as growth in the number of clinical-stage cell therapy pipelines, increasing applications of regenerative medicine in disease treatment, rising demand for advanced therapies, and growing R&D investment by pharmaceutical and biotech companies are contributing to the growth of the GMP cell therapy consumables market.
Global GMP cell therapy consumables market is estimated to be valued at USD 14.04 Mn in 2024 and is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.3% from 2024 to 2031.
As the GMP Cell Therapy Consumables Market Demand advances, there is an increasing for GMP-grade cell therapy consumables that can support high-quality and regulatory-compliant manufacturing processes. Various products such as media & sera, reagents, and storage & packaging products are widely utilized in cell processing, culture, and storage applications for different cell therapy formulations.
Key Takeaways
Key players operating in the GMP Cell Therapy Consumables are Thermo Fisher Scientific Inc., Lonza Group, Merck KGaA, Corning Inc., Sartorius AG, Danaher Corporation, Miltenyi Biotec, Stemcell Technologies Inc., GE Healthcare.
The growing adoption of regenerative medicines and strong clinical trial activity in cell-based therapies are driving the demand for customized cell processing solutions. Over 1,000 clinical trials using cell therapies are currently underway globally.
The market is witnessing expansion in emerging markets of Asia Pacific and Latin America due to favorable government policies, growing biopharmaceutical industry, and increasing healthcare expenditure.
Market Key Trends
Artificial intelligence (AI) is playing an increasingly important role in cell therapy manufacturing. AI-powered tools are being utilized for cell sorting, automated cell characterization, and real-time process monitoring in cell therapy manufacturing. AI can help enable personalized medicine approaches for cell therapies by supporting data-driven manufacturing. With advancements in AI, cell therapy manufacturing workflows are expected to become more standardized and scalable to meet growing commercial demands.
Porter’s Analysis
Threat of new entrants: Low capital requirements and technologies allow new players to enter the market easily.
Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power over suppliers due to their size and market share.
Bargaining power of suppliers: A small number of suppliers exist for critical raw materials and components used in cell therapy production, giving them strong bargaining power.
Threat of new substitutes: New technologies for genetic engineering and targeted therapies pose a threat of substitution in the long run.
Competitive rivalry: The market is consolidated with few global players dominating, leading to high competition in terms of technology and pricing.
Geographical Regions
North America accounted for the largest share of the global GMP cell therapy consumables market in 2024 due to the high adoption of CAR T-cell therapies and stem cell research. The region is home to many contract service providers and pharmaceutical companies focusing on cell-based immunotherapy research.
Asia Pacific is poised to grow at the fastest rate during the forecast period. This is attributed to increasing government funding to strengthen healthcare infrastructure, rising medical tourism, and growing focus on advanced cell-based research in China, Japan, and India. The expanding biotech industry in Asia Pacific offers ample opportunities for market players.
Discover the Report for More Insights, Tailored to Your Language:
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it.
About Author - Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
